It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Lipopolysaccharide (LPS) phase variation is a critical aspect of virulence in many Gram-negative bacteria. It is of particular importance to Coxiella burnetii, the biothreat pathogen that causes Q fever, as in vitro propagation of this organism leads to LPS truncation, which is associated with an attenuated and exempted from select agent status (Nine Mile II, NMII). Here, we demonstrate that NMII was recovered from the spleens of infected guinea pigs. Moreover, these strains exhibit a previously unrecognized form of elongated LPS and display increased virulence in comparison with the initial NMII strain. The reversion of a 3-bp mutation in the gene cbu0533 directly leads to LPS elongation. To address potential safety concerns, we introduce a modified NMII strain unable to produce elongated LPS.
In vitro propagation of the pathogenic bacterium Coxiella burnetii, the causative agent of Q fever, leads to attenuated virulence and lipopolysaccharide (LPS) truncation. Here, Long et al. show that a strain considered to be avirulent (NMII) can be recovered from infected animals, and these isolates display increased virulence and an elongated LPS due to reversion of a 3-bp mutation in a gene.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 National Institutes of Health, Laboratory of Bacteriology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, Hamilton, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
2 National Institutes of Health, Office of the Director, Office of Research Services, Division of Occupational Health and Safety, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
3 National Institutes of Health, Office of the Director, Office of Research Services, Division of Occupational Health and Safety, Hamilton, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
4 Washington State University, Paul G. Allen School for Global Health, College of Veterinary Medicine, Pullman, USA (GRID:grid.30064.31) (ISNI:0000 0001 2157 6568)
5 Northern Arizona University, Department of Biological Sciences, Center for Microbial Genetics and Genomics, Flagstaff, USA (GRID:grid.261120.6) (ISNI:0000 0004 1936 8040)